Results 151 to 160 of about 56,795 (260)

Is COVID-19 severity unrelated to antinuclear antibodies? [PDF]

Transpl Immunol, 2023
Vahabi M, Mirsharif ES, Ghazanfari T.
europepmc   +1 more source

Validity of Bioelectrical Impedance Analysis for the Assessment of Body Composition in Patients With Systemic Sclerosis

Journal of Cachexia, Sarcopenia and Muscle, Volume 17, Issue 2, April 2026.
ABSTRACT Background Systemic sclerosis (SSc) is an autoimmune disease characterized by vasculopathy and progressive fibrosis. Reduced muscle mass is common and contributes to myopenia, sarcopenia and adverse clinical outcomes. Dual‐energy X‐ray absorptiometry (DXA) is the most widely used method in clinical research and is recommended by international ...
Lucas Denardi Dória, Rafaela Cavalheiro do Espírito Santo, Vanessa Hax, André Luiz Mallmann, Leonardo Peterson dos Santos, Stephanie Pilotti, Daniel Nóbrega de Moraes, Bruno Eduardo Lara Da Silva, Vinícius Hammel Lovison, Ronaldo Legati Junior, Poliana Espíndola Correia, Tayane Muniz Fighera, Fernando Gerchman, Poli Mara Spritzer, Ricardo Machado Xavier, Rafael Mendonça da Silva Chakr   +15 more
wiley   +1 more source

The association between serum antinuclear antibodies and premature ovarian insufficiency: a meta-analysis. [PDF]

J Ovarian Res
Pi T, Hu Z, Luo L, Liu Z.
europepmc   +1 more source

Application and Challenges of Chimeric Antigen Receptor T Cell Therapy in Systemic Rheumatic Diseases and Autoimmune Disorders

MedComm, Volume 7, Issue 4, April 2026.
CAR‐T cell therapy in systemic rheumatic diseases and autoimmune disorders. (This figure was created using BioRender.com.) ABSTRACT Chimeric antigen receptor T (CAR‐T) cell therapy, originally developed for hematologic malignancies, has emerged as a transformative candidate for systemic rheumatic diseases and autoimmune disorders (AIDs).
Zhidan Fan, Li Zhang, Haiguo Yu
wiley   +1 more source

Change in Antinuclear Antibodies After Lung Transplantation in Patients with Systemic Sclerosis. [PDF]

J Clin Med
Barreales-Rodríguez V, Guillen-Del-Castillo A, Berastegui C, López-Meseguer M, Monforte V, Saez-Gimenez B, Villar A, Ojanguren I, Codina-Clavaguera C, Fernández-Luque A, Sanz-Martínez MT, Viñas-Giménez L, Perurena-Prieto J, Triginer-Gil L, Alcalá-González L, Bravo C, Simeón Aznar CP.   +16 more
europepmc   +1 more source

Elevated Polyreactive Immunoglobulin G in Immune‐Mediated Liver Injuries With the Need for Immunosuppressive Therapy

Liver International, Volume 46, Issue 4, April 2026.
ABSTRACT Background & Aims The distinction of drug‐induced liver injury (DILI), drug‐induced autoimmune‐like hepatitis (DI‐ALH), and autoimmune hepatitis (AIH) can be challenging due to overlapping clinical characteristics. Recently, polyreactive immunoglobulin G (pIgG) was identified as a novel biomarker in AIH.
Theresa Kirchner, George N. Dalekos, Kalliopi Zachou, Mercedes Robles‐Díaz, Raúl J. Andrade, Marcial Sebode, Ansgar Lohse, Maciej K. Janik, Piotr Milkiewicz, Mirjam Kolev, Nasser Semmo, Tony Bruns, Tom Jg. Gevers, Benedetta Terziroli Beretta‐Piccoli, Heiner Wedemeyer, Elmar Jaeckel, Richard Taubert, Bastian Engel, pIgG study group   +18 more
wiley   +1 more source

Prevalence and association testing of antinuclear antibodies and inflammatory bowel disease in Taiwan. [PDF]

PeerJ
Yang TM, Lu FT, Yen HH, Chen YY.
europepmc   +1 more source

Impact of antiphospholipid and antinuclear antibodies in coronary artery disease progression. [PDF]

Front Immunol
Garcia-Camarero T, Martínez-Taboada VM, Irure J, Hernández JMT, Comins-Boo A, López-Hoyos M, Hernández JL.   +6 more
europepmc   +1 more source

Epidemiological Analysis of Antinuclear Antibodies Positivity and Pattern Distribution in a Taiwanese Hospital-Based Cohort. [PDF]

Br J Biomed Sci
Tseng YW, Lin CL, Chen SY, Er TK.
europepmc   +1 more source

Importancia de indicar e interpretar las pruebas de autoanticuerpos

Revista Cubana de Medicina
La aceptación y la relevancia de los autoanticuerpos se evidencia por su creciente incorporación en los criterios diagnósticos y de clasificación de las enfermedades autoinmunes.
Elena Kokuina
doaj